1887

Abstract

The hepatitis C virus (HCV) non-structural (NS) 3/4A protein complex inhibits the retinoic acid inducible gene I (RIG-I) pathway by proteolytically cleaving mitochondria-associated CARD-containing adaptor protein Cardif, and this leads to reduced production of beta interferon (IFN-). This study examined the expression of CCL5 (regulated upon activation, normal T-cell expressed and secreted, or RANTES), CXCL8 (interleukin 8) and CXCL10 (IFN--activated protein 10, or IP-10) chemokine genes in osteosarcoma cell lines that inducibly expressed NS3/4A, NS4B, core-E1-E2-p7 and the entire HCV polyprotein. Sendai virus (SeV)-induced production of IFN-, CCL5, CXCL8 and CXCL10 was downregulated by the NS3/4A protein complex and by the full-length HCV polyprotein. Expression of NS3/4A and the HCV polyprotein reduced the binding of interferon regulatory factors (IRFs) 1 and 3 and, to a lesser extent, nuclear factor (NF)-B (p65/p50) to their respective binding elements on the CXCL10 promoter during SeV infection. Furthermore, binding of IRF1 and IRF3 to the interferon-stimulated response element-like element, and of c-Jun and phosphorylated c-Jun to the activator protein 1 element of the CXCL8 promoter, was reduced when NS3/4A and the HCV polyprotein were expressed. In cell lines expressing NS3/4A and the HCV polyprotein, the subcellular localization of mitochondria was changed, and this was kinetically associated with the partial degradation of endogenous Cardif. These results indicate that NS3/4A alone or as part of the HCV polyprotein disturbs the expression of IRF1- and IRF3-regulated genes, as well as affecting mitogen-activated protein kinase kinase- and NF-B-regulated genes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83316-0
2008-02-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/2/432.html?itemId=/content/journal/jgv/10.1099/vir.0.83316-0&mimeType=html&fmt=ahah

References

  1. Alexopoulou L., Holt A. C., Medzhitov R., Flavell R. A. 2001; Recognition of double-stranded RNA and activation of NF- κ B by Toll-like receptor 3. Nature 413:732–738 [CrossRef]
    [Google Scholar]
  2. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M. J. other authors 1997; Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94:1200–1205 [CrossRef]
    [Google Scholar]
  3. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254 [CrossRef]
    [Google Scholar]
  4. Casola A., Garofalo R. P., Jamaluddin M., Vlahopoulos S., Brasier A. R. 2000; Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J Immunol 164:5944–5951 [CrossRef]
    [Google Scholar]
  5. Cheng G., Zhong J., Chisari F. V. 2006; Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103:8499–8504 [CrossRef]
    [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299 [CrossRef]
    [Google Scholar]
  7. Ciccaglione A. R., Stellacci E., Marcantonio C., Muto V., Equestre M., Marsili G., Rapicetta M., Battistini A. 2007; Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol 81:202–214 [CrossRef]
    [Google Scholar]
  8. Ferreon J. C., Ferreon A. C., Li K., Lemon S. M. 2005; Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 280:20483–20492 [CrossRef]
    [Google Scholar]
  9. Foy E., Li K., Wang C., Sumpter R. Jr, Ikeda M., Lemon S. M., Gale M. Jr 2003; Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145–1148 [CrossRef]
    [Google Scholar]
  10. Foy E., Li K., Sumpter R. Jr, Loo Y. M., Johnson C. L., Wang C., Fish P. M., Yoneyama M., Fujita T. other authors 2005; Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 102:2986–2991 [CrossRef]
    [Google Scholar]
  11. Gack M. U., Shin Y. C., Joo C. H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z. other authors 2007; TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916–920 [CrossRef]
    [Google Scholar]
  12. Gale M. Jr, Foy E. M. 2005; Evasion of intracellular host defence by hepatitis C virus. Nature 436:939–945 [CrossRef]
    [Google Scholar]
  13. Genin P., Algarte M., Roof P., Lin R., Hiscott J. 2000; Regulation of RANTES chemokine gene expression requires cooperativity between NF- κ B and IFN-regulatory factor transcription factors. J Immunol 164:5352–5361 [CrossRef]
    [Google Scholar]
  14. Glisin V., Crkvenjakov R., Byus C. 1974; Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633–2637 [CrossRef]
    [Google Scholar]
  15. Green J., Khabar K. S., Koo B. C., Williams B. R., Polyak S. J. 2006; Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro . J Infect Dis 193:802–811 [CrossRef]
    [Google Scholar]
  16. Griffin S. D., Beales L. P., Clarke D. S., Worsfold O., Evans S. D., Jaeger J., Harris M. P., Rowlands D. J. 2003; The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535:34–38 [CrossRef]
    [Google Scholar]
  17. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. 2002; Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847–855
    [Google Scholar]
  18. Hugle T., Fehrmann F., Bieck E., Kohara M., Krausslich H. G., Rice C. M., Blum H. E., Moradpour D. 2001; The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 284:70–81 [CrossRef]
    [Google Scholar]
  19. Kato N., Yoshida H., Kioko Ono-Nita S., Kato J., Goto T., Otsuka M., Lan K., Matsushima K., Shiratori Y., Omata M. 2000; Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32:405–412 [CrossRef]
    [Google Scholar]
  20. Kaukinen P., Sillanpaa M., Kotenko S., Lin R., Hiscott J., Melen K., Julkunen I. 2006; Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J 3:66 [CrossRef]
    [Google Scholar]
  21. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K. J., Takeuchi O., Akira S. 2005; IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981–988 [CrossRef]
    [Google Scholar]
  22. Koike K., Miyoshi H. 2006; Oxidative stress and hepatitis C viral infection. Hepatol Res 34:65–73
    [Google Scholar]
  23. Koo B. C., McPoland P., Wagoner J. P., Kane O. J., Lohmann V., Polyak S. J. 2006; Relationships between hepatitis C virus replication and CXCL-8 production in vitro. J Virol 80:7885–7893 [CrossRef]
    [Google Scholar]
  24. Li K., Foy E., Ferreon J. C., Nakamura M., Ferreon A. C., Ikeda M., Ray S. C., Gale M. Jr, Lemon S. M. 2005a; Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102:2992–2997 [CrossRef]
    [Google Scholar]
  25. Li X. D., Sun L., Seth R. B., Pineda G., Chen Z. J. 2005b; Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102:17717–17722 [CrossRef]
    [Google Scholar]
  26. Lin R., Lacoste J., Nakhaei P., Sun Q., Yang L., Paz S., Wilkinson P., Julkunen I., Vitour D. & other authors (2006a). Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKϵ molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80:6072–6083 [CrossRef]
    [Google Scholar]
  27. Lin W., Kim S. S., Yeung E., Kamegaya Y., Blackard J. T., Kim K. A., Holtzman M. J., Chung R. T. 2006b; Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 80:9226–9235 [CrossRef]
    [Google Scholar]
  28. Lindenbach B. D., Rice C. M. 2005; Unravelling hepatitis C virus replication from genome to function. Nature 436:933–938 [CrossRef]
    [Google Scholar]
  29. Loo Y. M., Owen D. M., Li K., Erickson A. K., Johnson C. L., Fish P. M., Carney D. S., Wang T., Ishida H. other authors 2006; Viral and therapeutic control of IFN- β promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103:6001–6006 [CrossRef]
    [Google Scholar]
  30. Matikainen S., Ronni T., Hurme M., Pine R., Julkunen I. 1996; Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88:114–123
    [Google Scholar]
  31. Matikainen S., Siren J., Tissari J., Veckman V., Pirhonen J., Severa M., Sun Q., Lin R., Meri S. other authors 2006; Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 80:3515–3522 [CrossRef]
    [Google Scholar]
  32. Melchjorsen J., Jensen S. B., Malmgaard L., Rasmussen S. B., Weber F., Bowie A. G., Matikainen S., Paludan S. R. 2005; Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79:12944–12951 [CrossRef]
    [Google Scholar]
  33. Melen K., Fagerlund R., Nyqvist M., Keskinen P., Julkunen I. 2004; Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol 73:536–547 [CrossRef]
    [Google Scholar]
  34. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. 2005; Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172 [CrossRef]
    [Google Scholar]
  35. Miettinen M., Matikainen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., Julkunen I. 1998; Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66:6058–6062
    [Google Scholar]
  36. Moradpour D., Kary P., Rice C. M., Blum H. E. 1998; Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28:192–201
    [Google Scholar]
  37. Moradpour D., Brass V., Gosert R., Wolk B., Blum H. E. 2002; Hepatitis C: molecular virology and antiviral targets. Trends Mol Med 8:476–482 [CrossRef]
    [Google Scholar]
  38. Mukaida N., Okamoto S., Ishikawa Y., Matsushima K. 1994; Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56:554–558
    [Google Scholar]
  39. Nomura-Takigawa Y., Nagano-Fujii M., Deng L., Kitazawa S., Ishido S., Sada K., Hotta H. 2006; Non-structural protein 4A of hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol 87:1935–1945 [CrossRef]
    [Google Scholar]
  40. Ohmori Y., Hamilton T. A. 1993; Cooperative interaction between interferon (IFN) stimulus response element and κ B sequence motifs controls IFN γ - and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem 268:6677–6688
    [Google Scholar]
  41. Osterlund P., Veckman V., Siren J., Klucher K. M., Hiscott J., Matikainen S., Julkunen I. 2005; Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 79:9608–9617 [CrossRef]
    [Google Scholar]
  42. Otsuka M., Kato N., Moriyama M., Taniguchi H., Wang Y., Dharel N., Kawabe T., Omata M. 2005; Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41:1004–1012 [CrossRef]
    [Google Scholar]
  43. Piccoli C., Scrima R., D'Aprile A., Ripoli M., Lecce L., Boffoli D., Capitanio N. 2006; Mitochondrial dysfunction in hepatitis C virus infection. Biochim Biophys Acta 1757. 1429–1437
  44. Ray R. B., Steele R., Basu A., Meyer K., Majumder M., Ghosh A. K., Ray R. 2002; Distinct functional role of hepatitis C virus core protein on NF- κ B regulation is linked to genomic variation. Virus Res 87:21–29 [CrossRef]
    [Google Scholar]
  45. Schwer B., Ren S., Pietschmann T., Kartenbeck J., Kaehlcke K., Bartenschlager R., Yen T. S., Ott M. 2004; Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 78:7958–7968 [CrossRef]
    [Google Scholar]
  46. Seth R. B., Sun L., Ea C. K., Chen Z. J. 2005; Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- κ B and IRF 3. Cell 122:669–682 [CrossRef]
    [Google Scholar]
  47. Siren J., Pirhonen J., Julkunen I., Matikainen S. 2005; IFN- α regulates TLR-dependent gene expression of IFN- α , IFN- β , IL-28, and IL-29. J Immunol 174:1932–1937 [CrossRef]
    [Google Scholar]
  48. Veckman V., Osterlund P., Fagerlund R., Melen K., Matikainen S., Julkunen I. 2006; TNF- α and IFN- α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345:96–104 [CrossRef]
    [Google Scholar]
  49. Wagoner J., Austin M., Green J., Imaizumi T., Casola A., Brasier A., Khabar K. S., Wakita T., Gale M. Jr, Polyak S. J. 2007; Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol 81:309–318 [CrossRef]
    [Google Scholar]
  50. Wathelet M. G., Lin C. H., Parekh B. S., Ronco L. V., Howley P. M., Maniatis T. 1998; Virus infection induces the assembly of coordinately activated transcription factors on the IFN- β enhancer in vivo . Mol Cell 1:507–518 [CrossRef]
    [Google Scholar]
  51. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C. Y., Shyu A. B., Muller M., Gaestel M., Resch K., Holtmann H. 1999; The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969–4980 [CrossRef]
    [Google Scholar]
  52. Winzen R., Gowrishankar G., Bollig F., Redich N., Resch K., Holtmann H. 2004; Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24:4835–4847 [CrossRef]
    [Google Scholar]
  53. Wolk B., Sansonno D., Krausslich H. G., Dammacco F., Rice C. M., Blum H. E., Moradpour D. 2000; Subcellular localization, stability, and trans -cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 74:2293–2304 [CrossRef]
    [Google Scholar]
  54. Xu L. G., Wang Y. Y., Han K. J., Li L. Y., Zhai Z., Shu H. B. 2005; VISA is an adapter protein required for virus-triggered IFN- β signaling. Mol Cell 19:727–740 [CrossRef]
    [Google Scholar]
  55. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. 2002; Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN- β promoter in the Toll-like receptor signaling. J Immunol 169:6668–6672 [CrossRef]
    [Google Scholar]
  56. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. 2004; The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737 [CrossRef]
    [Google Scholar]
  57. Zhao T., Yang L., Sun Q., Arguello M., Ballard D. W., Hiscott J., Lin R. 2007; The NEMO adaptor bridges the nuclear factor- κ B and interferon regulatory factor signaling pathways. Nat Immunol 8:592–600 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83316-0
Loading
/content/journal/jgv/10.1099/vir.0.83316-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error